Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation (Q34113373)

31 July 2017

1 reference

title

Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation (English)

1 reference

31 July 2017

1 reference

1 reference

1 reference

Sharis M Simonian

1

1 reference

31 July 2017

Shahram Lotfipour

series ordinal

2

1 reference

31 July 2017

Christopher Wall

series ordinal

3

1 reference

31 July 2017

Mark I Langdorf

series ordinal

4

1 reference

31 July 2017

publication date

1 May 2010

1 reference

Internal and emergency medicine

31 July 2017

published in

1 reference

31 July 2017

volume

5

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

421-426

1 reference

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11739-010-0385-6

Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation

21 January 2018

1 reference

12 December 2020

Wolff-Parkinson-White syndrome presenting in atrial fibrillation

1 reference

12 December 2020

Amiodarone is poorly effective for the acute termination of ventricular tachycardia

1 reference

12 December 2020

Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the ED.

1 reference

12 December 2020

Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report

1 reference

12 December 2020

Myth: Intravenous amiodarone is safe in patients with atrial fibrillation and Wolff-Parkinson-White syndrome in the emergency department

1 reference

12 December 2020

Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation

1 reference

12 December 2020

The quest for a terminator

1 reference

12 December 2020

[Electrophysiological properties of atrial fibrillation with WPW syndrome and the role of procainamide in conversion]

1 reference

12 December 2020

Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation

1 reference

12 December 2020

Atrial Fibrillation in Wolff‐Parkinson‐White Syndrome: Reversal of Isoproterenol Effects by Sotalol

1 reference

12 December 2020

Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome

1 reference

12 December 2020

10.1007/S11739-010-0385-6

Identifiers

DOI

1 reference

31 July 2017

1 reference